U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8079180791Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive ImpairmentRecruitingNo Results AvailableStroke|Cognitive ImpairmentDrug: Galantamine|Drug: placebohttps://ClinicalTrials.gov/show/NCT01508494
8079280792Vitamin D Inadequacy is Associated With Incidence of Type 2 DiabetesCompletedNo Results AvailableType 2 Diabeteshttps://ClinicalTrials.gov/show/NCT01508481
8079380793Evaluate Rituximab Treatment for Idiopathic Membranous NephropathyActive, not recruitingNo Results AvailableIdiopathic Membranous NephropathyDrug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)|Drug: experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)https://ClinicalTrials.gov/show/NCT01508468
8079480794Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥ 28 Weeks to - CompletedHas ResultsAnesthesiaDrug: Midazolam|Drug: Fentanyl|Drug: Morphinehttps://ClinicalTrials.gov/show/NCT01508455
8079580795Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home BirthsRecruitingNo Results AvailablePostpartum Hemorrhage (PPH)Other: placebo|Drug: Misoprostolhttps://ClinicalTrials.gov/show/NCT01508429
8079680796Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple MyelomaCompletedNo Results AvailableMultiple Myelomahttps://ClinicalTrials.gov/show/NCT01508416
8079780797A Registry Study on Shuxuetong (a Chinese Medicine Injection) Used in Twenty HospitalsActive, not recruitingNo Results AvailableIschemic Strokehttps://ClinicalTrials.gov/show/NCT01508403
8079880798Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the ProstateRecruitingNo Results AvailableProstate CancerRadiation: CyberKnife Boosthttps://ClinicalTrials.gov/show/NCT01508390
8079980799Effects of an Internet-based Intervention for Posttraumatic Stress DisorderRecruitingNo Results AvailablePosttraumatic Stress Disorder (PTSD)Behavioral: Exposure for PTSD with cognitive restructuring|Behavioral: Exposure for PTSD without cognitive restructuringhttps://ClinicalTrials.gov/show/NCT01508377
8080080800Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell CarcinomaCompletedNo Results AvailableCarcinoma, Renal CellDrug: Sorafenib (Nexavar, BAY 43-9006)https://ClinicalTrials.gov/show/NCT01508364
8080180801The Hypotensive Effect of Propofol: an Observational StudyCompletedNo Results AvailableHypotension|Anesthesiahttps://ClinicalTrials.gov/show/NCT01508351
8080280802The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained AthletesCompletedNo Results AvailableHealthy Experienced Weight Training MalesDietary Supplement: Placebo|Dietary Supplement: HMB|Dietary Supplement: Peak ATP and HMB|Dietary Supplement: ATPhttps://ClinicalTrials.gov/show/NCT01508338
8080380803Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive PatientsCompletedHas ResultsHypertensionDrug: Bisoprolol|Drug: Metoprololhttps://ClinicalTrials.gov/show/NCT01508325
8080480804Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin LymphomaActive, not recruitingNo Results AvailableHodgkin's LymphomaDrug: brentuximab vedotin (SGN-35)|Drug: Brentuximab Vedotin (SGN-35)https://ClinicalTrials.gov/show/NCT01508312
8080580805Skin Prick Test for the Diagnosis of Food Allergy- a Comparison of Different Commercial Extracts and Raw FoodRecruitingNo Results AvailableFood AllergyProcedure: skin testhttps://ClinicalTrials.gov/show/NCT01508299
8080680806Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C SubjectsNo longer availableNo Results AvailableHepatitis CDrug: Telaprevir + peginterferon alfa + ribavirin|Drug: peginterferon alfa + ribavirin|Drug: peginterferon alfa + ribavirinhttps://ClinicalTrials.gov/show/NCT01508286
8080780807Lifestyle Intervention for High Risk Cancer SurvivorsActive, not recruitingNo Results AvailableBreast CancerBehavioral: Exercise Program|Behavioral: Website|Behavioral: Exercise DVD|Behavioral: Survey|Behavioral: Self-Report Assessmentshttps://ClinicalTrials.gov/show/NCT01508273
8080880808Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid OverloadWithdrawnNo Results AvailableLeukemiaProcedure: Aquapheresis|Drug: Furosemidehttps://ClinicalTrials.gov/show/NCT01508260
8080980809A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 MonthsCompletedNo Results AvailableHand, Foot and Mouth Disease|Herpangina|Other EV71-associated DiseasesBiological: inactivated vaccine (Vero Cell) against EV71|Biological: 0/0.5ml placebohttps://ClinicalTrials.gov/show/NCT01508247
8081080810Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation NecrosisRecruitingNo Results AvailableBrain MetastasisDrug: Trental|Dietary Supplement: Vitamin Ehttps://ClinicalTrials.gov/show/NCT01508221
8081180811Comparison of Urine Protein/Creatinine Ratio With 24-hour Urine Protein Excretion in Woman With Hypertensive DisordersRecruitingNo Results AvailableHypertension, Pregnancy-InducedOther: Hypertensive disorder of pregnancyhttps://ClinicalTrials.gov/show/NCT01508208
8081280812A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Canagliflozin tablets|Drug: Metformin IR tablets|Drug: Canagliflozin/metformin IR FDC tablets|Drug: Canagliflozin/metformin IR FDC tablets|Drug: Canagliflozin tablets|Drug: Metformin IR tabletshttps://ClinicalTrials.gov/show/NCT01508195
8081380813A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Canagliflozin tablets|Drug: Metformin IR tablets|Drug: Canagliflozin/metformin IR FDC tablets|Drug: Canagliflozin tablets|Drug: Metformin IR tablets|Drug: Canagliflozin/metformin IR FDC tabletshttps://ClinicalTrials.gov/show/NCT01508182
8081480814Foot Orthoses and Elderly Women With OsteoporosisCompletedHas ResultsOsteoporosisDevice: Foot orthosis (Orthotics Unit of the Clinical Hospital of UNICAMP)https://ClinicalTrials.gov/show/NCT01508169
8081580815Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)CompletedNo Results AvailableHepatitis C, ChronicDrug: IDX719|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01508156
8081680816Comparitive Study of Two Misoprostol Regimen in Early Pregnancy TerminationCompletedNo Results AvailableTerminationDrug: Misoprostol 400 micrograms|Drug: Misoprostol 800 microgramshttps://ClinicalTrials.gov/show/NCT01508143
8081780817An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1CompletedNo Results AvailableHepatitis C, Chronichttps://ClinicalTrials.gov/show/NCT01508130
8081880818Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) PatientsRecruitingNo Results AvailableGlioblastoma MultiformeDrug: Axitinib|Radiation: Radiation Therapyhttps://ClinicalTrials.gov/show/NCT01508117
8081980819Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid TumorsRecruitingNo Results AvailableCancerDrug: BEZ235|Drug: Everolimushttps://ClinicalTrials.gov/show/NCT01508104
8082080820Calorie Restriction Retards the Aging ProcessRecruitingNo Results AvailableObesityBehavioral: energy restricted mediterranean-type diet|Behavioral: 25 % calorie restrictionhttps://ClinicalTrials.gov/show/NCT01508091

* Görseller ve İçerik tekif hakkına sahip olabilir